That’s a possible conclusion to draw from Sweden’s HTA body The Dental and Pharmaceutical Benefits Agency, TLV‘s report published this week, on the topic of improving access to drugs for rare diseases.https://www.linkedin.com/company/tlv-the-dental-and-pharmaceutical-benefits-agency/
The pharmaceutical market has shifted in […]
In our latest publication in the Journal of Medical Economics, the cost-effectiveness of bimekizumab was assessed for the treatment of psoriatic arthritis in Sweden in collaboration with UCB and others.
According to Quantify Research co-author and payer expert Linnea […]
✨On Friday last week, Quantify Research held its annual fall kick-off in the beautiful city of #Stockholm! Full of energy and inspiration, we connected not only as colleagues, but as a vibrant, unified team celebrating many recent […]
The Quantify Research team can’t wait to see you at ISPOREurope in Copenhagen!
We are so excited to welcome all attendees to one of our home cities.
We will be exhibiting and presenting lots […]
Don’t miss it!
On October 4th and 5th, Quantify Research’s CEO Kirk Geale and Lead Analyst Alexander Rieem Dun will be instructing the ISPOR—The Professional Society for […]
